Prediction: This Is What Rivian Stock Will Do if the R2 Is a Smashing Success Don't assume an inflection point in deliveries will lead to an inflection point for shares.
Micron vs. SK Hynix: Which AI Memory Stock Is the Better Buy? Micron and SK Hynix are two of the leading companies fueling the artificial intelligence (AI) memory boom this year.
Better Robotics Stock: UiPath or Zebra Technologies The companies are helping drive increased automation in industrial applications.
Goldman Sachs Peaks, Joins 2 Best Stock Lists, Leads 16 New Names To IBD 50, Big Cap 20, More Stock of the Day Goldman Sachs reported terrific earnings Tuesday and rose above a buy level. Goldman was elevated onto two best stock lists.
Kestra Medical Technologies Q4 Earnings Call Highlights Kestra Medical Technologies (
NASDAQ:KMTS ) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetratio
Stock Market Today, July 14: IBM Plunges on Second-Quarter Warning as AI Shifts Enterprise Spending Today, July 14, 2026, customers redirected IT budgets away from software and infrastructure, raising questions about near-term demand durability.
Elon Musk's Tesla Posts Best Quarter in Two Years Tesla smashed delivery expectations, but was it just a fluke?
Stock Market Today, July 14: Lucid Group Plunges but Denies Reports About Bankruptcy Filing On July 14, 2026, shares tanked after reports that the EV maker was weighing restructuring options.
What This Cytokinetics Insider Sale Might Mean With the Stock Up 110% Blum exercised options at $10.60 per share and immediately sold them at $82.02, capturing gains from a 122% stock surge over the past year. He retains 381,986 shares and maintains a 0.31% ownership stake.
Why CleanSpark Stock Climbed Today Investors are celebrating a "transformational moment" for the digital infrastructure provider.
Amplitude vs. Agilysys: What Do the Revenue Trends for These Tech Companies Tell Investors? Amplitude leads in absolute sales, but Agilysys is closing the gap. Here's what the eight-quarter trend reveals about each company's growth momentum.
Olive Garden Follows McDonald’s Bet on Value: Will Never Ending Pasta Pass Strategy Work? Olive Garden looks to value with an annual promotion and the re-launch of the Pasta Pass to win over value-focused guests.
Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? Disposition represented 19% of insider's equity holdings under pre-established Rule 10b5-1 trading plan. Thurman retains 43,681 shares worth approximately $6.77 million.
Guidewire's CEO Sold $166,000 in Stock — Here's What Investors Should Know This sale was executed under a pre-established Rule 10b5-1 trading plan, reducing his direct holdings by 0.61%.
Palantir Trades at 64X Sales. Here's Whether That Premium Is Justified. The stock burned investors who shelled out for Palantir near the stock's highs last year.
Crypto Market Today, July 14: Ethereum Soars 6% on Cooler Inflation Data Today, July 14, 2026, softer CPI eased Fed tightening expectations, triggering a broad crypto rebound after earlier rate-hike jitters.
What This Rogers Corp Insider Transaction Means With EPS Up 178% This non-discretionary disposition tied to restricted stock unit vesting reduced his direct holdings by 19%, though he retains $5.16 million in equity.
